CUEDC2 Polyclonal antibody, PBS Only

CUEDC2 Polyclonal Antibody for WB, IHC, IF/ICC, IP, Indirect ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, IF/ICC, IP, Indirect ELISA

Conjugate

Unconjugated

Cat no : 20123-1-PBS

Synonyms

---

Validation Data Gallery

• 

  WB analysis using 20123-1-AP (same clone as 20123-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 20123-1-AP (CUEDC2 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  WB analysis of human brain using 20123-1-AP (same clone as 20123-1-PBS)

  human brain tissue were subjected to SDS PAGE followed by western blot with 20123-1-AP (CUEDC2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  WB analysis of human kidney using 20123-1-AP (same clone as 20123-1-PBS)

  human kidney tissue were subjected to SDS PAGE followed by western blot with 20123-1-AP (CUEDC2 antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  WB analysis of mouse kidney using 20123-1-AP (same clone as 20123-1-PBS)

  mouse kidney tissue were subjected to SDS PAGE followed by western blot with 20123-1-AP (CUEDC2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IP experiment of mouse brain using 20123-1-AP (same clone as 20123-1-PBS)

  IP result of anti-CUEDC2 (IP:20123-1-AP, 4ug; Detection:20123-1-AP 1:500) with mouse brain tissue lysate 4000ug. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human ovary tumor using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human ovary tumor tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human ovary tumor using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human ovary tumor tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human malignant melanoma using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human malignant melanoma tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 40x lens).. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human malignant melanoma using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human malignant melanoma tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 40x lens).. This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human breast cancer using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human breast cancer using 20123-1-AP (same clone as 20123-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 20123-1-AP (CUEDC2 antibody) at dilution of 1:800 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

• 

  IF Staining of HeLa using 20123-1-AP (same clone as 20123-1-PBS)

  Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using CUEDC2 antibody (20123-1-AP) at dilution of 1:200 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (SA00013-2). This data was developed using the same antibody clone with 20123-1-PBS in a different storage buffer formulation.

---

Product Information

20123-1-PBS targets CUEDC2 in WB, IHC, IF/ICC, IP, Indirect ELISA applications and shows reactivity with human, mouse samples.

• Tested Reactivity: human, mouse
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: CUEDC2 fusion protein Ag13847
• Full Name: CUE domain containing 2
• Calculated Molecular Weight: 287 aa, 32 kDa
• Observed Molecular Weight: 32 kDa
• GenBank Accession Number: BC000262
• Gene Symbol: CUEDC2
• Gene ID (NCBI): 79004
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity purification
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

CUE domain-containing 2 (CUEDC2) is a ubiquitin-binding motif-containing protein involved in the regulation of the cell cycle, inflammation, and tumorigenesis. It is ubiquitously expressed in human tissues and organs, not only highly expressed in the normal brain, heart and testis, but also some kinds of cancers, such as breast, ovarian and kidney cancers. CUEDC2 could act as an adaptor protein to target IκB kinase (IKK) for dephosphorylation and inactivation by recruiting protein phosphatase (PP1), and thus repressed activation of the transcription factor NF-κB. Moreover, CUEDC2, is a key factor in endocrine resistance in breast cancer.